James Shorter and postdoctoral fellow Meredith Jackrel of the Perelman School of Medicine are featured for their research on “reprogrammed” yeast protein that could lead to new brain disease therapies.
Perelman School of Medicine
Researchers at Penn Medicine have generated a brain development index from MRI scans that captures the complex patterns of maturation during normal brain development.
Steve Larson and student Daphne Owen of the Perelman School of Medicine comment on Penn’s Puentes de Salud program.
The Perelman School of Medicine's Michael Levy is quoted on his research of a dreaded household pest.
Penn Medicine: Unraveling Misfolded Molecules Using "Reprogrammed" Yeast Protein Could Lead to New Brain Disease Therapies
At the heart of brain diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease, and Parkinson's disease is protein misfolding, in which distorted proteins are unable to perform their normal functions. At present, there is no known way to reverse protein misfolding.
Penn Medicine: Silencing Inhibitor of Cell Replication Spurs Insulin-producing Beta Cells to Reproduce
Penn Medicine Study Finds No Significant Differences Between Commonly Used Carotid Stenting Systems in U.S.
A study conducted by researchers from several institutions, including the Perelman School of Medicine at the University of Pennsylvania, has found similarly low rates of complication and death among U.S. patients who are treated with the three most common systems for placing stents in blocked carotid arteries of the neck.
Jun Zhu of the Perelman School of Medicine says, “We always suspected that the classical strain caused all those pandemics.”